Patents by Inventor Christopher D. Batich

Christopher D. Batich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5719138
    Abstract: The metal ion complexing properties exhibited by dicitrate are disclosed as chelating agents for reducing the amounts of metal ions in a substance.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: February 17, 1998
    Assignee: University of Florida
    Inventors: William C. Thomas, Jr., Christopher D. Batich, Daniel L. Purich
  • Patent number: 5607417
    Abstract: A method for the controlled release of a biologically active agent wherein the agent is released from a hydrophobic, pH-sensitive polymer matrix is disclosed and claimed. The polymer matrix swells when the environment reaches pH 8.5, releasing the active agent. A polymer of hydrophobic and weakly acidic comonomers is disclosed for use in the controlled release system. Further disclosed is a specific embodiment in which the controlled release system may be used. The pH-sensitive polymer is coated onto a latex catheter used in ureteral catheterization. A common problem with catheterized patients is the infection of the urinary tract with ureaseproducing bacteria. In addition to the irritation caused by the presence of the bacteria, urease produced by these bacteria degrade urea in the urine, forming carbon dioxide and ammonia. The ammonia causes an increase in the pH of the urine. Minerals in the urine begin to precipitate at this high pH, forming encrustations which complicate the functioning of the catheter.
    Type: Grant
    Filed: February 1, 1995
    Date of Patent: March 4, 1997
    Assignee: CApHCO, Inc.
    Inventors: Christopher D. Batich, Marc S. Cohen, Kirk Foster
  • Patent number: 5607964
    Abstract: Treating patients prophylactically and therapeutically with dicitrate cyclic diester (dicitrate) can prevent or reduce the effects of calcification-related disease, including some types of kidney stones.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: March 4, 1997
    Assignee: University of Florida
    Inventors: William C. Thomas, Jr., Christopher D. Batich, Daniel L. Purich
  • Patent number: 5604103
    Abstract: Dicitrate cyclic diester (dicitrate) is a novel compound which is found in patients who do not exhibit symptoms or predisposition to idiopathic renal calculous disease. Kits are provided for the detection of dicitrate cyclic diester.
    Type: Grant
    Filed: June 17, 1994
    Date of Patent: February 18, 1997
    Assignee: University of Florida
    Inventors: William C. Thomas, Jr., Christopher D. Batich, Daniel L. Purich
  • Patent number: 5601804
    Abstract: Dicitrate cyclic diester (dicitrate) is a novel compound which is found in patients who do not exhibit symptoms or predisposition to idiopathic renal calculous disease. Dicitrate can be isolated and detected by novel chromatographic methods. Further, treating patients prophylactically and therapeutically with dicitrate cyclic diester can prevent or reduce the effects of calcification-related disease, including some types of kidney stones, or other disease or condition associated with the presence of metal ions. The metal ion complexing properties exhibited by dicitrate are also applicable to the use of the subject compounds as chelating agents and methods of binding, and thereby reducing, the amounts of metal ions in a substance.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: February 11, 1997
    Assignee: The University of Florida
    Inventors: William C. Thomas, Jr., Christopher D. Batich, Daniel L. Purich
  • Patent number: 5554147
    Abstract: A method for the controlled release of a biologically active agent wherein the agent is released from a hydrophobic, pH-sensitive polymer matrix is disclosed and claimed. The polymer matrix swells when the environment reaches pH 8.5, releasing the active agent. A polymer of hydrophobic and weakly acidic comonomers is disclosed for use in the controlled release system. Further disclosed is a specific embodiment in which the controlled release system may be used. The pH-sensitive polymer is coated onto a latex catheter used in ureteral catheterization. A common problem with catheterized patients is the infection of the urinary tract with urease-producing bacteria. In addition to the irritation caused by the presence of the bacteria, urease produced by these bacteria degrade urea in the urine, forming carbon dioxide and ammonia. The ammonia causes an increase in the pH of the urine. Minerals in the urine begin to precipitate at this high pH, forming encrustations which complicate the functioning of the catheter.
    Type: Grant
    Filed: February 1, 1994
    Date of Patent: September 10, 1996
    Assignee: CApHCO, Inc.
    Inventors: Christopher D. Batich, Marc S. Cohen, Kirk Foster
  • Patent number: 5550259
    Abstract: Dicitrate cyclic diester (dicitrate) is a novel compound which is found in patients who do not exhibit symptoms or predisposition to idiopathic renal calculous disease. Dicitrate can be isolated and detected by novel chromatographic methods. Further, treating patients prophylactically and therapeutically with dicitrate cyclic diester can prevent or reduce the effects of calcification-related disease, including some types of kidney stones, or other disease or condition associated with the presence of metal ions. The metal ion complexing properties exhibited by dicitrate are also applicable to the use of the subject compounds as chelating agents and methods of binding, and thereby reducing, the amounts of metal ions in a substance.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: August 27, 1996
    Assignee: The University of Florida
    Inventors: William C. Thomas, Jr., Christopher D. Batich, Daniel L. Purich
  • Patent number: 5532029
    Abstract: This invention relates to novel compositions containing temporary visual indicators and methods for using these compositions. Specifically, this invention relates to a sunscreen composition containing an indicator that is visible when the substance is applied to the skin, but becomes invisible shortly after application. The continued presence of the indicator allows the indicator to be reactivated temporarily to the visible form so that a user can verify the presence of the sunscreen. The visible indicator ensures that the sunscreen is applied evenly and completely to the area to be protected, but becomes invisible so as not to interfere with the action of the sunscreen or discolor the skin.
    Type: Grant
    Filed: February 14, 1995
    Date of Patent: July 2, 1996
    Inventors: Ronnie S. Fuerst, Richard Melker, Christopher D. Batich
  • Patent number: 5523075
    Abstract: This invention relates to novel compositions containing temporary visual indicators and methods for using these compositions. Specifically, this invention relates to a sunscreen composition containing an indicator that is visible when the substance is applied to the skin, but becomes invisible shortly after application. The continued presence of the indicator allows the indicator to be reactivated temporarily to the visible form so that a user can verify the presence of the sunscreen. The visible indicator ensures that the sunscreen is applied evenly and completely to the area to be protected, but becomes invisible so as not to interfere with the action of the sunscreen or discolor the skin.
    Type: Grant
    Filed: May 13, 1993
    Date of Patent: June 4, 1996
    Inventors: Ronnie S. Fuerst, Richard J. Melker, Christopher D. Batich
  • Patent number: 5376553
    Abstract: Dicitrate cyclic diester (dicitrate) is a novel compound which is found in patients who do not exhibit symptoms or predisposition to idiopathic renal calculous disease. Dicitrate can be isolated and detected by novel chromatographic methods. Further, treating patients prophylactically and therapeutically with dicitrate cyclic diester can prevent or reduce the effects of calcification-related disease, including some types of kidney stones.
    Type: Grant
    Filed: June 18, 1993
    Date of Patent: December 27, 1994
    Assignee: University of Florida
    Inventors: William C. Thomas, Jr., Christopher D. Batich, Daniel L. Purich
  • Patent number: 5322165
    Abstract: A sharp instrument encasement system is disclosed for encasing the sharp points or edges of medical instruments. The system comprises a container having two fluid-tight compartments separated by a frangible membrane, one compartment containing a hardenable resin and the other containing a filler comprising a particulate material that is substantially incompressible. Upon insertion of a medical instrument through a penetrable top and through the frangible membrane, the contents of the compartments mix, creating a reaction that hardens the resin and particulate material mixture and encases the sharp portions of the medical instrument.
    Type: Grant
    Filed: February 16, 1993
    Date of Patent: June 21, 1994
    Assignee: University of Florida
    Inventors: Richard J. Melker, Gary J. Miller, Christopher D. Batich
  • Patent number: 5278110
    Abstract: A method of preparing preceramic SiC fibers having a very low oxygen content by forming fibers from a solution of a polycarbosilane and a vinylic sic precursor in a mutual volatile solvent, heating fibers in an oxygen-free inert s atmosphere to effect a cross-linking reaction therebetween. Also disclosed is a method of preparing SiC fibers having superior high temperature properties and a very low oxygen content comprising beating the above-described cross-linked preceramic fibers in an inert atmosphere substantially free of oxygen for a time and at a temperature sufficient to pyrolyze the cross-linked fibers to SiC fibers. The disclosure also describes the novel fibers produced by the above-described methods.
    Type: Grant
    Filed: March 5, 1993
    Date of Patent: January 11, 1994
    Assignee: University of Florida
    Inventors: William Toreki, Christopher D. Batich
  • Patent number: 5242870
    Abstract: A method of preparing preceramic SiC fibers having a very low oxygen content by forming fibers from a solution of a polycarbosilane and a vinylic SiC precursor in a mutual volatile solvent, heating fibers in an oxygen-free inert atmosphere to effect a cross-linking reaction therebetween. Also disclosed is a method of preparing SiC fibers having superior high temperature properties and a very low oxygen content comprising heating the above-described cross-linked preceramic fibers in an inert atmosphere substantially free of oxygen for a time and at a temperature sufficient to pyrolyze the cross-linked fibers to SiC fibers. The disclosure also describes the novel fibers produced by the above-described methods.
    Type: Grant
    Filed: May 22, 1992
    Date of Patent: September 7, 1993
    Assignee: University of Florida
    Inventors: William Toreki, Christopher D. Batich
  • Patent number: 5171722
    Abstract: A method of preparing preceramic SiC fibers having a very low oxygen content by forming fibers from a solution of a polycarbosilane and a vinylic SiC precursor in a mutual volatile solvent, heating fibers in an oxygen-free inert atmosphere to effect a cross-linking reaction therebetween. Also disclosed is a method of preparing SiC fibers having superior high temperature properties and a very low oxygen content comprising heating the above-described cross-linked preceramic fibers in an inert atmosphere substantially free of oxygen for a time and at a temperature sufficient to pyrolyze the cross-linked fibers to SiC fibers. The disclosure also describes the novel fibers produced by the above-described methods.
    Type: Grant
    Filed: October 9, 1991
    Date of Patent: December 15, 1992
    Assignee: University of Florida
    Inventors: William Toreki, Christopher D. Batich
  • Patent number: 4728694
    Abstract: A process for grafting acrylamide onto the surface of low density polyethylene (LDPE). The LDPE is first oxidized by a chromic acid solution and then reduced with diborane to produce a hydroxyl-rich surface. Acrylamide is then grafted onto the surface of the LDPE by free-radical initiation, resulting in a hydrophilic polyacrylamide layer covalently bonded to the LDPE. The process has no effect on the bulk properties of the LDPE.
    Type: Grant
    Filed: May 8, 1987
    Date of Patent: March 1, 1988
    Assignee: University of Florida
    Inventors: Christopher D. Batich, Ali Yahiaoui